New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin: Intestinal inflammation, colon cancer, and melatonin
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
In intestinal bowel disease (IBD), immune-mediated conditions exert their effects through various cells and proinflammatory mediators. Recent data support a participation of the endoplasmic reticulum stress and mitochondrial dysfunctions in IBD. Moreover, it is evident that chronic degenerative pathologies, including IBD, share comparable disease mechanisms with alteration in the autophagy mechanisms. Chronic inflammation in IBD exposes these patients to a number of signals known to have tumorigenic effects. This circuitry of inflammation and cancer modifies apoptosis and autophagy, and promotes cellular cycle progression, invasion, and angiogenesis. Melatonin has been shown as a specific antioxidant reducing oxidative damage in both lipid and aqueous cell environments. However, several studies provide further insight into the molecular mechanisms of melatonin action in the colon. In this line, recent data suggest that melatonin modulates autophagy and sirtuin activity. An anti-autophagic property of melatonin has been demonstrated, and it could contribute to its anti-oncogenic activity. Nevertheless, there is no information about whether antitumoral effects of melatonin on colon cancer are dependent on autophagy. Sirtuins have pleiotropic effects on cancer development, being reported both as facilitator and as suppressor of colon cancer development. Sirtuins and melatonin are connected through the circadian clock machinery, and melatonin seems able to correct the alterations in sirtuin activity associated with several pathological conditions. Autophagy and sirtuin activities are linked through 5'AMP-activated protein kinase (AMPK) activation, which switches on autophagy and increases sirtuin. The effect of melatonin on AMPK and the impact of this effect on IBD and colon cancer remain an open question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Studies on yeast, worms, flies, and mice point to a role for nutrient-responsive molecules, such as SIRT1 and mTOR, in aging and CR [105].”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 1×
“An autophagy relationship with sirtuins has been demonstrated and includes AMPK, which senses the intracellular AMP/ATP ratio and inhibits mTOR-dependent signaling [107] while augmenting cellular NAD levels [108].”
BackgroundPolakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“In addition, SIRT1 is a negative regulator of NFkB activity through the deacetylation of the p65 lysine 310 [93].”
BackgroundCaloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · cited 1×
“The relationship and mechanisms through which infection and inflammation increase cancer risk and promote tumor development have been recently the object of extensive discussion [49, 56].”
BackgroundKaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., et al. (2007) · Nature Genetics · doi:10.1038/ng2032 · Cited by 1,769 · cited 1×
“Association between two genes, the autophagy-related 16-like 1 gene, ATG16L1 and IRGM, and CD was identified by a genome study and by a wide single-nucleotide polymorphism (SNP) study [16, 17].”
BackgroundInflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Travassos, L. H., Carneiro, L. A. M., Ramjeet, M., Hussey, S., Kim, Y.-G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1823 · Cited by 1,306
Regulation of autophagy by cytoplasmic p53
Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1730 · Cited by 1,132
Martin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588 · cited 3×
“SIRT1 suppresses intestinal tumorigenesis and colon cancer growth in a b-catenin-driven mouse model of colon cancer [97].”
BackgroundInfluentialMetabolism and cancer: the circadian clock connection
Sahar, S., & Sassone-Corsi, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2747 · Cited by 551
Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential
Salminen, A., Lehtonen, M., Suuronen, T., Kaarniranta, K., & Huuskonen, J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8103-5 · Cited by 406 · cited 1×
“At present, there is significant enthusiasm for in vitro and animal studies for the use of specific NF-kB inhibitors as new anticancer therapy [63, 64].”
BackgroundMelatonin: A Pleiotropic Molecule Regulating Inflammation
Radogna, F., Diederich, M., & Ghibelli, L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.041 · Cited by 342
Melatonin: Action as antioxidant and potential applications in human disease and aging
Bonnefont-Rousselot, D., & Collin, F. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.008 · Cited by 320
Clinical Uses of Melatonin: Evaluation of Human Trials
Sanchez-Barcelo, E. J., Mediavilla, M. D., Tan, D. X., & Reiter, R. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791233689 · Cited by 301
The life span-prolonging effect of Sirtuin-1 is mediated by autophagy
Morselli, E., Maiuri, M. C., Markaki, M., Megalou, E., Pasparaki, A., Palikaras, K., Criollo, A., Galluzzi, L., Malik, S. A., Vitale, I., et al. (2010) · Autophagy · doi:10.4161/auto.6.1.10817 · Cited by 139
Cited by
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
Galano, A., Tan, D. X., & Reiter, R. J. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12010 · Cited by 795
Melatonin: Buffering the Immune System
Carrillo-Vico, A., Lardone, P., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048638 · Cited by 740
Tian, T., Wang, Z., & Zhang, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4535194 · Cited by 714
Zhang, N., Zhao, B., Zhang, H., Weeda, S., Yang, C., Yang, Z., Ren, S., & Guo, Y. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01015.x · Cited by 636
Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Metadata
- Authors
- Motilva, V., García-Mauriño, S., Talero, E., & Illanes, M.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2011-07-13
- Volume
- 51
- Issue
- 1
- Pages
- 44-60
- ISSN
- 0742-3098 (ISSN-L)
- OpenAlex
- W1480722843
- Cited by
- 106
- References
- 20
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.